Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04419961
Other study ID # PSD20
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 15, 2020
Est. completion date December 1, 2021

Study information

Verified date August 2021
Source National Hospital of Obstetrics and Gynecology
Contact Thanh C Phan, MD
Phone +84948226044
Email drthanh.nhog@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Sexual dysfunction is common in pregnant women (46.6%, 34.4%, and 73.3% in women in the first, second, and third trimester worldwide, respectively). These dysfunctions can persist after childbirth, affecting quality of life, marriage satisfaction, and family happiness. In Vietnam, a country heavily influenced by the Eastern traditions, sexual activity is considered private and only shared between husband and wife. Many women have wrong beliefs that having sexual intercouse during pregnancy will affect the safety of the fetus, and thus, are reluctant to engage in sexual activity with their husband. Interventions have been developed to improve the quality of sexual function in pregnant women. In Vietnam, data of sexual dysfunction in pregnant women are somewhat limited, and there have been no programs to improve the sexual function for this population. Therefore, the study team plans to develop an educational program with aim to improve the quality of sexual function in Vietnamese pregnant women. This study aims to investigate the prevalence and associated factors of sexual dysfunction in first-trimester pregnant women and evaluate the effectiveness of the educational program.


Recruitment information / eligibility

Status Recruiting
Enrollment 350
Est. completion date December 1, 2021
Est. primary completion date October 1, 2021
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - Pregnant women whose gestational age is less than or equal to 12 weeks. - Currently living with husband/partner. - No signs and symptoms of first trimester complications (eg, threated abortion). Exclusion Criteria: - Getting pregnant from in vitro fertilization or having a history of preterm birth. - Having serious health conditions that require abortion. - Illiterate, or having mental illness or incapacity. - Having a fetus diagnosed with anomalies. - Does not agree to participate.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Educational program
The educational program includes a group discussion and a booklet. The group discussion lasts for 90 minutes, discussing importance of sexual activity during pregnancy, improving sexual experience during pregnancy, physical and mental changes of pregnant women, and measures to cope with discomfort, anxiety, fear and other issues. It includes a 30-minutes presentation, followed by 1-hour discussion. The booklet is a color-printed A5-size booklet containing in-depth information of the content given during the discussion. Each participant can only receive one copy of the booklet, and the booklet is not given to the control participants.

Locations

Country Name City State
Vietnam National Hospital of Obstetrics and Gynecology Hanoi

Sponsors (1)

Lead Sponsor Collaborator
National Hospital of Obstetrics and Gynecology

Country where clinical trial is conducted

Vietnam, 

Outcome

Type Measure Description Time frame Safety issue
Primary Prevalence of sexual dysfunction in pregnant women Sexual function is evaluated using the Female Sexual Function Index (FSFI). The FSFI includes 19 questions covering six domains: desire, arousal, lubrication, orgasm, satisfaction, and pain. Questions ask about participant's sexual experience during the past four weeks, rating the degree/frequency of their experience on a scale from "not at all" or "never" to "very" or "always". Four questions score 1-5 and fifteen score 0-5. Then, the scores of questions in an individual domain are added and the total score is multiplied by the domain factor. Finally, the six domain scores are added to obtain the full scale score. A total FSFI score of <= 26.55 is considered sexual dysfunction. Baseline
Primary Change in the FSFI score from baseline to two months Patients are followed up after two months and repeated the FSFI. The difference between the baseline total FSFI score and the two-month total FSFI score is calculated. The mean difference is calculated for the intervention and the control arm. Two months
Secondary Change in knowledge and attitude at two months Knowledge and attitude are assessed by asking participants whether they agree or disagree with 24 statements. These statements are developed based on the key messages of the educational program. K/A assessment is repeated at two months. We calculate the proportion of participants who have changes in knowledge and attitude after the educational program. Two months
See also
  Status Clinical Trial Phase
Completed NCT05806424 - Investigation of Awareness Levels of Women Living in Turkey About Kegel Exercises and Pelvic Floor Muscles
Completed NCT01364623 - PK Study of Testosterone Nasal Gel (TBS-2) in Healthy Premenopausal Women Phase 1
Completed NCT06060691 - the Ameliorating Effects of Antioxidant Gel on Female Arousal Disorder and Sexual Dysfunction Phase 1
Completed NCT04122703 - Trial of Tibial Nerve Stimulation for Treating Sexual Dysfunction N/A
Recruiting NCT03498443 - Effect of Pelvic Organ Prolapse Surgeries on Female Sexual Function in Egyptian Women
Completed NCT03232801 - A Mindfulness-based Intervention for Older Women With Low Sexual Desire N/A
Completed NCT04124640 - Observational Study in Real Life to Describe the Libicare® Effectiveness in Female Sexual Dysfunction.
Completed NCT00995072 - Comparative Effects of Nebivolol and Metoprolol on Female Sexual Function N/A
Active, not recruiting NCT05168371 - Cognitive-Behavioural & Mindfulness-Based Online Programs for Female Sexual Dysfunction N/A
Completed NCT04384172 - Effect of Peripheral Neuromodulation on Vaginal Blood Flow N/A
Recruiting NCT06237166 - Evaluation of an Online Intervention for Female Sexual Dysfunction N/A
Completed NCT03463707 - BP101 for Adults With Female Sexual Dysfunction Phase 3
Recruiting NCT01078077 - The Impact of a Topical Vasodilating Cream on Female Sexual Experience N/A
Completed NCT01724658 - Effectiveness of Testosterone Undecanoate to Improve Sexual Function in Postmenopausal Women Phase 2
Completed NCT02229721 - Effect of Chronic Intranasal Oxytocin Administration on Sexual Function in Pre- and Postmenopausal Women Phase 2
Completed NCT00479570 - Study To Investigate Effect Of A New Drug (PF-00446687) In Post-Menopausal Women Who Suffer From Sexual Dysfunction. Phase 2
Not yet recruiting NCT06116045 - Evaluation of the Efficacy, Safety and Tolerability of BZ371A in Women With Sexual Arousal Disorder Phase 2
Withdrawn NCT02862184 - Female Sexual Dysfunction, Risks and Outcomes (FSFI) N/A
Completed NCT01195701 - Clitoral Location in Relation to Sexual Function Using Pelvic Imaging N/A
Completed NCT04484753 - Validation of iPelvis App for Female Pelvic Floor Dysfunction N/A